Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

YOQNEAM, Israel and SAN RAMON, California, January 9 /PRNewswire/ -- Renowned plastic surgeons and dermatologists from Europe, the Middle East, Asia and the Americas will present their latest findings from clinical experience with UltraShape during the 10th annual IMCAS meeting held in Paris, France from January 9th - 12th, 2008.

UltraShape is the clinically proven non-invasive solution for fat reduction and body contouring using "non-thermal" selective focused ultrasound technology. Seven leading physicians specializing in the field of aesthetic medicine will present clinical results on the effectiveness of UltraShape's Contour I in reducing fat thickness and improving body contours.

LONDON, January 9 /PRNewswire/ -- New research showing that anti-psychotic drugs are not an effective treatment for aggression in patients with learning disabilities(1), has further underlined concerns about over-prescribing for mental health. A Healthcare Commission report last year found that up to one in three mental health patients were over-prescribed to, and recently American research has suggested that stimulant medication such as Ritalin are not viable long-term treatment solutions(2).

SHEFFIELD, England, January 9 /PRNewswire/ -- Disenco Energy plc (TSX:DIS) today announces the appointment of Autocraft Industries UK as the volume engine manufacturer for its unique home energy producing and carbon footprint cutting appliance, HomePowerPlant. The appointment follows months of discussions with potential business partners with Autocraft, a subsidiary of Aftermarket Technology Corp. (NASDAQ: ATAC), being chosen because of its outstanding manufacturing facilities, expertise and engine-building track record for such customers as Aston Martin, Ford Motor Company and General Motors.

MUNICH, Germany, January 9 /PRNewswire/ --

- ANDTEK Exhibits Highly Advantageous Unified Communications Solutions

- Legally Recognized Telephone Conversation Recording

ANDTEK GmbH presents intelligent and client-specific, unified communications applications and value-added services for business, industry, financial companies, legal firms and the health-care sector at the "Cisco Networkers 2008," which takes place in Barcelona from January 21 - 24.

The Munich-based unified communications specialist is exhibiting high-quality solutions at stand E61 in the "Unified Communications World" area, including, for example, the "AND Phone Recorder," which enables the recording of IP-based phone calls (Voice over IP, VoIP).

NEW YORK, January 9 /PRNewswire/ --

Investment firm W. P. Carey & Co. LLC (NYSE: WPC) announced today that CPA(R):14, its publicly held non-traded REIT affiliate, acquired an industrial/office research facility in Turku, Finland for approximately EUR 10 million.

The facility is being leased to Wallac Oy, a subsidiary of PerkinElmer, Inc., under a long-term lease. The acquisition is a follow-on transaction to an approximately EUR 28 million sale-leaseback of an adjacent research and production facility that CPA(R):14 completed with PerkinElmer in 2001. Both properties are located in Turku's "Bio Valley" - a section of the city named for its comprehensive infrastructure of science, business and biotech-related services.

CHAPEL EN LE FRITH, England, January 9 /PRNewswire/ -- Peakdale Molecular Ltd a leading provider in specialist chemistry services to the pharmaceutical industry has announced today that they have successfully completed a GBP1m round of equity funding which will enable Peakdale to continue the expansion of its facilities in the UK to support its continued rapid growth.

The investors in this round were led by Solon Ventures LP, advised by Solon Ventures Ltd, and were supported by a number of existing investors.